| Document Date: 2014-06-23 14:25:34
Open Document File Size: 97,86 KBShare Result on Facebook
City Mississauga / / Company Novo Nordisk Canada Inc. / Roper / Diabète Québec / Novo Nordisk A/S / Jeremy Brace Novo Nordisk Canada Inc. / / Country Canada / / Currency USD / / / Event FDA Phase / / IndustryTerm healthcare system / pre-filled pen injection device / diabetes care / pharmaceutical products / healthcare / / MedicalCondition sometimes fatal disease / diabetes / Obesity / hypoglycemia / About Diabetes / / Organization Canadian Diabetes Association / Québec government / Mathieu Gaudreault TACT Intelligence / Québec Health Insurance Board / / Person Serge Langlois / Rémi Rabasa-Lhoret / André Bélanger / Sylvie / Bertrand / Université de Montréal / / / Position Prime Minister / leader / President and CEO / spokesperson / physician / associate professor / / Product glucagon / Victoza® (liraglutide) / / Technology biopharmaceuticals / GPS / / URL http /
SocialTag |
Québec Becomes First Province to Add Victoza® to the Drug Benefit Formulary* for the Treatment of Type 2 Diabetes Mississauga, ON – June 4, 2014 – Novo Nordisk today announces that the Québec government has approv